AI assistant
Sending…
AstraZeneca PLC — AGM Information 2021
May 11, 2021
5229_rns_2021-05-11_2cbf4d6f-e39a-4504-b406-82d03ba85439.pdf
AGM Information
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}
RESOLUTIONS
OF
ASTRAZENECA PLC (the "Company")
Registered Number: 2723534 Registered in England & Wales
At a General Meeting of the Company, duly convened, and held at Academy House, 136 Hills Road, Cambridge CB2 8PA on Tuesday 11 May 2021 at 11.30 a.m. (BST) the following resolution was duly passed as an ordinary resolution:
1. THAT:
- (a) the proposed acquisition by the Company of Alexion Pharmaceuticals, Inc. and the associated arrangements to be entered into, all as described in the circular to the shareholders of the Company dated 12 April 2021 and substantially on the terms and subject to the conditions set out in the Merger Agreement dated 12 December 2020 between the Company and Alexion Pharmaceuticals, Inc. (among others) (the "Transaction"), be and is hereby approved; and
- (b) the directors of the Company (the "Directors") (or any duly constituted committee thereof) be and are hereby authorised to take all necessary or appropriate steps and to do all necessary or appropriate things to implement, complete or procure the implementation or completion of the Transaction and give effect thereto with such modifications, variations, revisions, waivers or amendments (not being modifications, variations, revisions, waivers or amendments of a material nature) as the Directors (or any duly authorised committee thereof) may deem necessary, expedient or appropriate in connection with the Transaction.
________________
Adrian Kemp Company Secretary
More from AstraZeneca PLC
Foreign Filer Report
2026
May 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 1
Regulatory Filings
2026
May 1
Regulatory Filings
2026
May 1
Regulatory Filings
2026
May 1
Foreign Filer Report
2026
Apr 29
Earnings Release
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Foreign Filer Report
2026
Apr 28
Regulatory Filings
2026
Apr 28